» Authors » Noemi Garcia-Romero

Noemi Garcia-Romero

Explore the profile of Noemi Garcia-Romero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 457
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carrillo-Beltran D, Nahuelpan Y, Cuevas C, Fabres K, Silva P, Zubieta J, et al.
Cells . 2025 Feb; 14(3). PMID: 39936970
Glioblastoma (GB) is a highly malignant brain tumor with a poor prognosis, with a median survival of only 14.6 months despite aggressive treatments. Resistance to chemotherapy, particularly temozolomide (TMZ), is...
2.
Palacin-Aliana I, Garcia-Romero N, Carrion-Navarro J, Puig-Serra P, Torres-Ruiz R, Rodriguez-Perales S, et al.
Int J Mol Sci . 2024 Oct; 25(20). PMID: 39456686
The isolation of circulating tumoral DNA (ctDNA) present in the bloodstream brings about the opportunity to detect genomic aberrations from the tumor of origin. However, the low amounts of ctDNA...
3.
Villoch-Fernandez J, Martinez-Garcia N, Martin-Lopez M, Maeso-Alonso L, Lopez-Ferreras L, Vazquez-Jimenez A, et al.
Mol Oncol . 2024 Aug; 19(3):852-877. PMID: 39090849
Glioblastoma (GB) is the most common and fatal type of primary malignant brain tumor for which effective therapeutics are still lacking. GB stem cells, with tumor-initiating and self-renewal capacity, are...
4.
Aljama S, Lago E, Zafra O, Sierra J, Simon D, Santos C, et al.
Crit Rev Oncol Hematol . 2023 Jul; 189:104067. PMID: 37454703
Colorectal cancer (CRC) is the third most common malignant tumor and one of the deadliest cancers. At molecular level, CRC is a heterogeneous disease that could be divided in four...
5.
Peris-Celda M, Carrion-Navarro J, Palacin-Aliana I, Sanchez-Gomez P, Prat Acin R, Garcia-Romero N, et al.
Front Oncol . 2022 Sep; 12:923681. PMID: 36091108
Gliomas are the most common brain tumors, which present poor prognosis, due, in part, to tumor cell migration and infiltration into distant brain areas. However, the underlying mechanisms causing such...
6.
Erices J, Niechi I, Uribe-Ojeda A, Toro M, Garcia-Romero N, Carrion-Navarro J, et al.
Front Oncol . 2022 Sep; 12:969993. PMID: 36059665
Glioblastoma (GBM) is the most common and deadly malignant brain tumor, with a median survival of 15 to 17 months for a patient. GBM contains a cellular subpopulation known as...
7.
Pienkowski T, Kowalczyk T, Garcia-Romero N, Ayuso-Sacido A, Ciborowski M
Biochim Biophys Acta Rev Cancer . 2022 Mar; 1877(3):188721. PMID: 35304294
The diagnosis of glioma is mainly based on imaging methods that do not distinguish between stage and subtype prior to histopathological analysis. Patients with gliomas are generally diagnosed in the...
8.
Hernandez Martinez A, Madurga R, Garcia-Romero N, Ayuso-Sacido A
Cancer Lett . 2021 Dec; 527:66-79. PMID: 34902524
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper understanding of...
9.
Duraj T, Carrion-Navarro J, Seyfried T, Garcia-Romero N, Ayuso-Sacido A
Mol Metab . 2021 Nov; 54:101389. PMID: 34749013
Background: Aberrant metabolism is recognized as a hallmark of cancer, a pillar necessary for cellular proliferation. Regarding bioenergetics (ATP generation), most cancers display a preference not only toward aerobic glycolysis...
10.
Palacin-Aliana I, Garcia-Romero N, Asensi-Puig A, Carrion-Navarro J, Gonzalez-Rumayor V, Ayuso-Sacido A
Biomedicines . 2021 Aug; 9(8). PMID: 34440110
Cancer is one of the leading causes of death worldwide and remains a major public health challenge. The introduction of more sensitive and powerful technologies has permitted the appearance of...